Flagship Pioneering has announced the formation of Etcelera, a company created by the merger of the platforms of Cellarity, Etiome and Empress Therapeutics. The new company aims to pioneer causal intelligence in human biology: the ability to determine what truly drives disease and predict how a medicine… Read More
Merck is expanding access to TEDDY (Transformers for Enabling Drug DiscoverY), its foundation model for drug discovery, by adding it to HuggingFace, the premier platform for open-source machine learning and LLMs. TEDDY was created in partnership with the Boston Consulting Group (BCG) AI Science Institute and is… Read More
AstraZeneca, Tempus AI and Pathos AI have entered a multi-year, strategic collaboration to build a multimodal foundation model in oncology. The model will be used to gather biological and clinical insights, discover novel drug targets, and develop therapeutics for the broader oncology community. Upon completion,… Read More
